Clinical Trials
5 trialsNCT04554914 2026-04-27
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Pierre Fabre Medicament
Phase 2 Active not recruiting
NCT03333486 2025-07-04
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00968864 2022-04-22
T-cell Depleted Alternative Donor Transplantation
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed
NCT01050439 2015-04-15
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Columbia University
Phase 2 Terminated